Site search
2831 results for '' found
IDE196 (DAROVASERTIB) IN COMBINATION WITH CRIZOTINIB VERSUS INVESTIGATOR’S CHOICE OF TREATMENT AS FIRST-LINE THERAPY IN HLA-A2 NEGATIVE METASTATIC UVEAL MELANOMA (DAR-UM-2) (NCT05987332)
IDE196 (DAROVASERTIB) IN COMBINATION WITH CRIZOTINIB VERSUS INVESTIGATOR’S CHOICE OF TREATMENT AS FIRST-LINE THERAPY IN HLA-A2 NEGATIVE METASTATIC UVEAL MELANOMA (DAR-UM-2) (NCT05987332)
/
The Intelligent Computerized Engine (ICE) Aspiration System Clinical Study: First In Human
The Intelligent Computerized Engine (ICE) Aspiration System Clinical Study: First In Human
/
An immune-therapeutic salvage strategy for ‘functional’ high-risk (FHR) multiple myeloma incorporating Iberdomide, Isatuximab, and Dexamethasone (Iber-IsaDex) – the IBIS study (ACTRN1262100103789
An immune-therapeutic salvage strategy for ‘functional’ high-risk (FHR) multiple myeloma incorporating Iberdomide, Isatuximab, and Dexamethasone (Iber-IsaDex) – the IBIS study (ACTRN1262100103789
/
A Phase 1 Open-Label Study to Assess the Safety, Pharmacokinetics, and Anti-tumor Activity of Oral HP518 in Patients with Metastatic Castration-Resistant Prostate Cancer HP518-CS-001 (NCT05252364
A Phase 1 Open-Label Study to Assess the Safety, Pharmacokinetics, and Anti-tumor Activity of Oral HP518 in Patients with Metastatic Castration-Resistant Prostate Cancer HP518-CS-001 (NCT05252364
/
HOME-AKI: Haemofiltration with Oxiris: Multicentre Evaluation in Acute Kidney Injury (U1111-1247-3435)
HOME-AKI: Haemofiltration with Oxiris: Multicentre Evaluation in Acute Kidney Injury (U1111-1247-3435)
/
A phase 3, multicenter, open-label, randomized, study of gilteritinib versus midostaurin in combination with induction and consolidation therapy followed by one year maintenance in patients with
A phase 3, multicenter, open-label, randomized, study of gilteritinib versus midostaurin in combination with induction and consolidation therapy followed by one year maintenance in patients with
/
Home-based Minimal Equipment Exercise Training (H-MEET) delivered using remote supervision: A randomised controlled feasibility study (ACTRN12625000550404)
Home-based Minimal Equipment Exercise Training (H-MEET) delivered using remote supervision: A randomised controlled feasibility study (ACTRN12625000550404)
/
Expanded study of the HighLife™ 28mmtranscatheter trans-septal mitral valve in patients with moderatesevere or severe mitral regurgitation and at high surgical risk (NCT04029363)
Expanded study of the HighLife™ 28mmtranscatheter trans-septal mitral valve in patients with moderatesevere or severe mitral regurgitation and at high surgical risk (NCT04029363)
/
Use of the Hexoskin shirt for assessment of patients with dysfunctional breathing compared to healthy controls (Trial Not Registered)
Use of the Hexoskin shirt for assessment of patients with dysfunctional breathing compared to healthy controls (Trial Not Registered)
/
HELIOS-B: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopat
HELIOS-B: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopat
/